A Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix™ / Influsplit SSW® 2008/2009 in Adults
Clinical trial NCT00706563 · COMPLETED
Trial details
- NCT number
- NCT00706563
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-07
- Primary completion
- 2008-07-30
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.